VEEVVeeva Systems

$322.95+10% 1Y
Latest close: a new 52-week highOct 23, 2026what changed →

Is the price fair?

Fair

The yardsticks disagree: cheap against its own 5-year P/E range (15th percentile) but the cash-flow math implies demanding growth. Treat as fair, not cheap.

1 good, 1 to watch, 1 without data
Vs its own P/E rangecheaper than 85% of its own historyderived

Cheap vs its own history: P/E 52.9 vs a 71.4 median over 41 quarters (−26% vs median).

Vs sector (EV/EBIT)44.2×derived · Jul 31, 2026

Sector median 25.1× across 135 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 89% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What VEEV's price assumes

Veeva Systems trades at 52.9× earnings against 46.9× for the median Health Information Services name, more expensive than its own group.

52.9

Trailing P/E · Health Information Services median 46.9 · 1.13× the median: the market pays up for this one

Price / sales
15.1

Price / sales · today's price, trailing year to Jul 31, 2026

Price / book
7.04

Price / book · today's price, trailing year to Jul 31, 2026

EV / sales
13.2

EV / sales

Details›
Price / booktoday's price, trailing year to Jul 31, 2026
7.04
EV / EBITtoday's price, trailing year to Jul 31, 2026
44.2
EV / salestoday's price, trailing year to Jul 31, 2026
13.2
Healthcare median P/E503 names
27.9
Health Information Services median P/E24 names
46.9
Market capitalisation161.9 million shares, counted Aug 25, 2026
$52.3B
What the market has paid for these earnings: 41 quarters of its own multiple × $6.11 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$346.83
Its own P/E history, median$436.05
Its own P/E history, upper quartile$549.53
52-week range$151.43 – $322.94
Today$322.95

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.